Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Perrigo's over-the-counter (OTC) Minoxidil Foam's abbreviated new drug application (ANDA).
Subscribe to our email newsletter
Perrigo ‘s Minoxidil Foam is the generic version of Men’s Rogaine Foam, used to regrow hair on the top of the scalp.
Earlier, GSK company Stiefel Research Australia had filed a lawsuit against Perrigo on Minoxidil Foam ANDA, which has been settled in February 2011.
According to the settlement agreement, Perrigo has received rights to launch the generic version of Men’s Rogaine Foam in the US on 1 March 2012, or earlier, under certain circumstances.
Perrigo chairman and CEO Joseph Papa said this is another example of Perrigo’s commitment to bring new products to market.